2026杭州国际中医药盛会暨《六合辨证》传承拜师礼圆满落幕

医者大道，生生不息；中医文脉，薪火相传。2026年4月18日，钱塘潮起，医韵云集，一场兼具传承深度与国际格局的中医药文化盛典落地杭州。世界中医药学会联合会一技之长专业委员会会长、厚德为怀医生集团副主席曹东义教授《六合辨证》传承拜师仪式隆重举行，同步启幕的还有中国·杭州国际中医药传承发展大会暨第四届中俄传统医学交流大会，以学术为桥，以传承为魂，奏响新时代中医药振兴发展的铿锵乐章。

中医药作为中华优秀传统文化的璀璨瑰宝，历经数千年岁月淬炼，早已形成自成体系的生命智慧与诊疗哲学。《黄帝内经》有言：“上古圣人，不治已病治未病，不治已乱治未乱”，这份根植于华夏沃土的整体观、辨证观，时至今日依旧闪耀着穿越时空的智慧光芒。本次《六合辨证》传承拜师活动，正是对古训的当代践行，也为中医绝学的有序传承筑牢了人才根基。

本次拜师仪式阵容规整、格局开阔，汇聚来自泰国及中国大陆的二十位中医传承人，正式纳入第二批“举”字辈传承谱系，为《六合辨证》学术体系注入新生力量。俄罗斯联邦巴士科尔托斯坦共和国医学会阿扎马特主席亲临现场见证盛典，跨国界的见证之举，既印证了中医药文化的国际吸引力，也体现出传统医学跨越地域、文明互通的独特价值。

同日举办的国际中医药传承发展大会，规模盛况空前，汇聚海内外业内专家学者五百余人齐聚杭州，共探传统医学传承创新之路，共商中医药国际化发展大计。连续举办的中俄传统医学交流大会，更是搭建起中俄两国传统医学互鉴互融的优质平台，打破学术壁垒，实现经验共享、理念共生，让东西方传统医学在交流碰撞中迸发全新活力。

在主旨报告环节，曹东义会长以《筑牢中医根基，才能行稳致远》为题发表深度分享。大道之行，本固枝荣，中医的发展从不是浮于表面的追逐浮华，而是深耕本源、守正笃行的久久为功。在当下多元医疗环境之下，中医药想要行稳致远，既要守住经典理论的根脉，吃透古法辨证的核心精髓，又要顺应时代发展潮流，以开放视野拥抱交流、拥抱创新。不盲从浮躁风气，不偏离中医本源，方能让千年医道在新时代行而不辍、历久弥新。

纵观整场盛会，既有师徒赓续的文脉传承，也有跨国对话的学术格局；既有经典智慧的回望坚守，也有面向未来的发展思考。二十名传承人接续薪火，五百位专家共话发展，跨国嘉宾共襄盛举，一组组鲜活的数据，勾勒出中医药复兴的蓬勃态势。

中医复兴，从来不是一句空泛的口号，而是一代又一代医者的接续耕耘；文化传承，也不是固步自封的守旧，而是守正创新的兼容并蓄。此次杭州盛会，既是对中医药古老智慧的致敬，也是对未来发展的擘画。

潮起钱塘风正劲，医道传承再出发。立足当下，中医药正站在文化自信与国际交流的双重风口，相信在一代代传承人的坚守与努力下，在国际医学的交流互鉴之中，中华中医药定能赓续千年文脉，立足华夏，走向世界，在新时代焕发出更加璀璨夺目的光彩。

作者简介：梁世杰，京畿瘤科创始人，出身中医世家，原首都医科大学中医门诊部主治医师，毕业于河北医科大学，深耕中医肿瘤临床与科研25年。为国医大师、肝病泰斗关幼波，风湿病泰斗焦树德学术思想第三代传人，师承首都医科大学附属北京中医院肝病科知名老中医陈勇，侍诊研习多年，尽得真传，学验俱丰。

一、学术思想与诊疗特色

作为中医肿瘤领域体系化创新学者，首创“稳态抗癌”核心学术体系，提出从“以毒攻毒”向“稳态和谐”范式转型，以“平秘阴阳、祛邪解毒、护固正气”为治疗总则，立足《黄帝内经》“正气存内”理念，明确肿瘤为全身失衡的局部显现，通过调理脏腑气血、改善“癌状态”体质、切断肿瘤微环境，实现高质量带瘤生存，为中晚期肿瘤治疗确立“以人为本、生命优先”的价值导向。

临床构建“辨病+辨证+辨体”三辨精准诊疗模式，融合抗癌专病专方与“商汤经方分类疗法”、关幼波十纲辨证与焦树德学术思想，创新“易学中医辩证哲学思维模式”及象数五行体质应用；用药恪守平和中正、攻补兼施、顾护胃气原则，坚持全周期协同治疗、心身同调，实现个体化、低损伤、长获益的肿瘤诊疗目标。

二、学术与科研成果

主编专著：《梁世杰中医肿瘤治疗学》《商汤经方分类疗法》，均获国家版权登记；

发明专利：“三花五子六白散”治疗肺癌国家发明专利1项；

学术论文：发表《古方青龙丸治疗中晚期肺癌20例》等多篇肿瘤领域高价值学术论文。

三、学术任职

中国抗癌协会会员

卫生部中国医促会中医肿瘤防治专委会委员

中国药文化研究会中医药慢病防治分会首批癌症领域入库专家

四、荣誉与影响力

先后荣获第八届医圣仲景南阳论坛“经方名医”、首届京津冀“扁鹊杯”燕赵医学征文优秀奖、卫生部全国医学学术一等奖。学术事迹荣登《中华英才》《当代科学家》等权威期刊，是国内中医肿瘤领域理论体系完整、学术特色鲜明、临床疗效确切的实力派专家。

五、擅长诊疗范围

甲状腺癌、鼻咽癌、肺癌、肺结节、乳腺癌、食管癌、胃癌、萎缩性胃炎、肠化生、肠癌、肝癌、胰腺癌、肾癌、膀胱癌、前列腺癌、淋巴瘤、脑瘤、宫颈癌、卵巢癌等各类中晚期良恶性肿瘤，及术后康复、放化疗减毒增效、防复发转移等疑难病症。

Sharing the thousand-year medical heritage and holding high the banner of traditional Chinese medicine renaissance - Hangzhou International Traditional Chinese Medicine Event and "Phoenix Dialectics" Transmission of Teachers Service completed successfully

The Way of Healing goes on forever; The traditional Chinese medicine is taught by fire. On April 18, 2026, Qiantang surged, medical poetry gathered, and a celebration of Chinese medicine culture with a depth of heritage and an international pattern landed in Hangzhou. Professor Cao Dongyi, President of the Professional Committee of the Federation of Pharmaceutical Societies of the World and Vice Chairman of the Hode Weiwei Medical Group, held a grand ceremony to honor the teachers of Feng Shui Dialect. Also inaugurated at the same time were the China Hangzhou International Conference on the Replication and Development of Chinese Medicine and the Fourth China-Russia Traditional Medical Exchange Conference. With academics as a bridge and heritage as the soul, the sound of the revitalization and development of Chinese medicine in the new era was sounded.

As a splendid treasure of China's excellent traditional culture, traditional Chinese medicine has evolved over thousands of years and has long ago formed its own system of life wisdom and philosophy of diagnosis and treatment. The Huangdi Yin scripture says, "The ancient saints, who have not healed a disease, have not healt a disorder, have not yet healed chaos." This holistic view and dialectical view, which is rooted in the fertile soil of China, still shines with wisdom through time and space. This "Phoenix Dialectics" inheritance and teacher visiting activity is precisely the contemporary practice of ancient teaching and establishes the foundation of talent for the orderly inheritance of traditional Chinese medicine.

The ceremony gathered 20 inheritors of traditional Chinese medicine from Thailand and Chinese Mainland, which was officially included in the second batch of "Ju" generation pedigree, injecting new strength into the academic system of Liuhe Dialectics. Chairman Azamat of the Medical Association of the Republic of Bashkortostan, Russian Federation, witnessed the event at the scene. The act of witnessing across national borders not only confirmed the international appeal of traditional medicine culture, but also demonstrated the unique value of traditional medical science across geographical boundaries and civilization exchanges.

On the same day, the international conference on the inheritance and development of traditional Chinese medicine was of unprecedented scale, bringing together more than 500 experts and scholars from both domestic and overseas to Hangzhou to explore the way of inheritance of traditional medicine and explore the international development of Traditional Chinese medicine. The successive China-Russia Convention on Traditional Medicine Exchange has established a high-quality platform for mutual learning and mutual understanding between China and Russia in traditional medicine, breaking down academic barriers, sharing experiences and symbiosis of ideas, and giving new vitality to East-West traditional medicine in the exchange collision.

During the keynote speech, Chairman Cao Dongyi released an in-depth sharing under the title "Strengthening the foundation of traditional Chinese medicine to achieve steady and lasting progress." The road to the heavens is not a superficial chase for flashes, but rather a long-term effort to cultivate the roots and practice the principles. In the current multi-disciplinary medical environment, in order to achieve steady progress in traditional Chinese medicine, we must not only maintain the roots of classical theory, but also understand the core essence of ancient dialectical interpretation, and follow the trend of the times to open our eyes to embrace communication and innovation. Without blindly following the fickle spirit and deviating from the original sources of traditional Chinese medicine, we can make the thousand-year medical practice continue to be practiced and continue to be renewed in the new era.

Throughout the entire event, there was both the continuity of the teachings and the academic pattern of transnational dialogue. There is both the retention of classical wisdom and development thinking for the future. Twenty inheritors continued their careers, 500 experts talked about development, and multinational guests celebrated the event. Groups of vivid data outlined the booming trend of the revival of Chinese medicine.

The revival of traditional Chinese medicine has never been an empty slogan, but rather the continued work of generations of healers. Cultural inheritance is not a rigid adherence to old trends, but an eclectic mix of adherence and innovation. This Hangzhou event is not only a tribute to the ancient wisdom of Chinese medicine, but also a drawing of the future development.

The tide of Qiantang became strong, and the inheritance of medical science began again. At present, traditional Chinese medicine is standing at the crossroads of cultural confidence and international exchanges. It is believed that with the commitment and efforts of generations of inheritors and in international medical exchanges and mutual learning, Chinese traditional medicine will continue the millennia-old tradition, stand firm in China, go global, and shine even brighter in the new era.

Author profile: Liang Shi-jie, the founder of the Jingyi Tumor Clinic, hails from a family of traditional Chinese medicine practitioners. He was a chief physician at the Traditional Chinese Medicine Outpatient Clinic of the former Capital Medical University. He graduated from Hebei Medical University and has devoted 25 years to clinical practice and research in traditional Chinese medicine oncology. He is the third generation of the academic lineage of Guan You-bo, a master of traditional Chinese medicine and a renowned expert in liver diseases, and Jia Shu-de, a master of rheumatology. He studied under Chen Yong, a well-known elderly traditional Chinese medicine practitioner in the liver disease department of Beijing Traditional Chinese Medicine Hospital affiliated to the Capital Medical University. He has gained extensive knowledge and experience through many years of study and practice.

I. Academic Thought and Diagnostic/Therapeutic Specialties

As a scholar specializing in systematized innovation in the field of traditional Chinese medicine oncology, I pioneered the core academic system of “steady state anti-cancer.” I proposed a transition from the paradigm of “using poison to counter poison” to “steady state harmony,” with the general principles of “balancing Yin and Yang, eliminating evil and detoxifying, and protecting and reinforcing healthy qi.” Grounded in the concept of “healthy qi resides within” from the Huangdi Neijing, I clarified that tumors are localized manifestations of overall imbalance. By regulating the qi and blood of internal organs, improving the “cancer state” constitution, and disrupting the microenvironment of tumors, we can achieve high-quality survival with a tumor present, thereby establishing a value orientation of “people-centeredness and prioritizing life” for the treatment of advanced and late-stage tumors.

Clinical construction of the “diagnosis + syndrome differentiation + constitution identification” three-step precise diagnosis and treatment model, integration of cancer-specific treatments and “Shang Tang classic prescription classification therapy,” Guan Youbo’s ten-category syndrome differentiation method, and Jiao Shude’s academic thoughts, innovation of the “easy-to-learn traditional Chinese medicine dialectical philosophical thinking mode” and the application of symbolic number and five-element constitution; adhering to the principles of moderation and balance, combining attack and supplementation, and protecting the stomach qi, maintaining comprehensive and coordinated treatment throughout the entire cycle, balancing mind and body, and achieving personalized, low-injury, and long-term benefits in cancer diagnosis and treatment.

II. Scholarly and Research Achievements

Co-authored monographs: “Liang Shi-jie’s Traditional Chinese Medicine for Cancer Treatment” and “Shang Tang’s Classification Therapy Based on Classical Prescriptions”; both have been registered for national copyright protection.

Patent for invention: One national patent for the invention of “Sanhua Wu Zi Li Bai San” for the treatment of lung cancer.

Academic Papers: Published numerous high-value academic papers in the field of oncology, including “The Treatment of 20 Cases of Advanced-Stage Lung Cancer with Ancient Formula Qinglong Pill.”

III. Academic Positions

Member of the Chinese Cancer Association.

Member, Expert Committee on Traditional Chinese Medicine Cancer Prevention and Treatment, China Medical Promotion Association, Ministry of Health.

First-batch cancer-related experts inducted into the Chinese Traditional Medicine Prevention and Treatment of Chronic Diseases Branch of the Chinese Pharmaceutical Culture Research Association.

IV. Recognition and Influence

He has been awarded the title of “Expert in Traditional Medicine” at the Eighth Symposium of the Medicine Saint Zhongniang of Nanyang, the Outstanding Award for Medical Writing at the First Beijing-Tianjin-Hebei “Bian Que Cup” Symposium on Yan-Zhao Medicine, and the First Prize for Medical Scholarship by the Ministry of Health. His academic achievements have been featured in prestigious journals such as “China’s Elite” and “Contemporary Scientists.” He is a highly respected expert in the field of traditional Chinese medicine oncology, known for his comprehensive theoretical framework, distinctive academic characteristics, and proven clinical efficacy.

V. Areas of Expertise

Thyroid cancer, nasopharyngeal cancer, lung cancer, pulmonary nodules, breast cancer, esophageal cancer, gastric cancer, atrophic gastritis, intestinal metaplasia, intestinal cancer, liver cancer, pancreatic cancer, kidney cancer, bladder cancer, prostate cancer, lymphoma, brain tumors, cervical cancer, ovarian cancer, and other various advanced and late-stage benign and malignant tumors, as well as post-operative rehabilitation, radiation and chemotherapy to reduce toxicity and enhance efficacy, and prevention of recurrence and metastasis, among other complex conditions.